Names | |
---|---|
Preferred IUPAC name
2-(3-Chloro-2-methylanilino)pyridine-3-carboxylic acid | |
Other names
Clonixic acid; CBA 93626
[1]
| |
Identifiers | |
3D model (
JSmol)
|
|
ChEBI |
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.037.921 |
KEGG | |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C13H11ClN2O2 | |
Molar mass | 262.69 g·mol−1 |
Pharmacology | |
per os | |
Pharmacokinetics: | |
Glucuronidation via UGT2B7 | |
Legal status |
|
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
Clonixin is a nonsteroidal anti-inflammatory drug (NSAID). It also has analgesic, antipyretic, and platelet-inhibitory actions. It is used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation.
The glyceryl ester of clonixin, clonixeril, is also an NSAID. It was prepared by a somewhat roundabout method.
Clonixin was reacted with chloroacetonitrile and triethylamine to give 2. Heating with potassium carbonate and glycerol acetonide displaced the activating group to produce ester 3, which was deblocked in acetic acid to produce clonixeril (4).
Names | |
---|---|
Preferred IUPAC name
2-(3-Chloro-2-methylanilino)pyridine-3-carboxylic acid | |
Other names
Clonixic acid; CBA 93626
[1]
| |
Identifiers | |
3D model (
JSmol)
|
|
ChEBI |
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.037.921 |
KEGG | |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C13H11ClN2O2 | |
Molar mass | 262.69 g·mol−1 |
Pharmacology | |
per os | |
Pharmacokinetics: | |
Glucuronidation via UGT2B7 | |
Legal status |
|
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
Clonixin is a nonsteroidal anti-inflammatory drug (NSAID). It also has analgesic, antipyretic, and platelet-inhibitory actions. It is used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation.
The glyceryl ester of clonixin, clonixeril, is also an NSAID. It was prepared by a somewhat roundabout method.
Clonixin was reacted with chloroacetonitrile and triethylamine to give 2. Heating with potassium carbonate and glycerol acetonide displaced the activating group to produce ester 3, which was deblocked in acetic acid to produce clonixeril (4).